|
|
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.
Cyanide works by making the human body unable to use oxygen.
Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.
More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.